Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrition and treated with peptide YY and clenbuterol

Nutrition
W T ChanceA Balasubramaniam

Abstract

Prevention of gut hypoplasia associated with total parenteral nutrition (TPN) was investigated in 67 adult male Fisher 344 rats. Mass and protein content of the small intestine was reduced by 31% and 39%, respectively, after 7 d of TPN in tumor-bearing (TB) rats. Coinfusing peptide YY (PYY; 1 nmol.kg-1.h-1) and treating the rats with the anabolic beta-adrenergic agonist, clenbuterol (CLE; 2 mg.kg-1.d-1), resulted in significant savings in small intestine weight (26% increase) and protein (42% increase). Although the colon also exhibited a significant decrease in mass (31%), none of the treatment combinations were effective in this region of the gut. Histologic analysis of ileum suggested that the additive effects of PYY and CLE were due to differential effects of these compounds on mucosal and muscular tissues, respectively. This combination of treatments also resulted in significant savings (30% increase) in gastrocnemius protein, suggesting a reduction in the cachectic response. These results suggest that TPN-induced gut hypoplasia and cancer cachexia may be reduced by the proper combination of nutritional, hormonal, and pharmacologic treatments. In addition, the anabolic effects of various treatments may be additive to count...Continue Reading

References

May 1, 1992·Digestive Diseases and Sciences·N J Andrews, M H Irving
Mar 1, 1992·JPEN. Journal of Parenteral and Enteral Nutrition·A L Buchman
Jan 1, 1991·The Journal of Surgical Research·D W BensonJ E Fischer
Sep 1, 1991·JPEN. Journal of Parenteral and Enteral Nutrition·W T ChanceJ E Fischer
Mar 1, 1991·The Journal of Trauma·W T ChanceJ E Fischer
Sep 1, 1989·Metabolism: Clinical and Experimental·J K EadaraD R Romsos
Jun 1, 1989·Metabolism: Clinical and Experimental·J K EadaraD R Romsos
Sep 15, 1986·Cancer·S KleinG L Blackburn
Jul 1, 1986·The British Journal of Nutrition·P J ReedsR M Palmer
Nov 1, 1985·Gastroenterology·T E AdrianS R Bloom
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K Tatemoto
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M LundbergB Hamberger
Sep 1, 1995·The Journal of Surgical Research·A StallionJ E Fischer
Nov 1, 1993·British Journal of Pharmacology·A T NialsC J Vardey
Mar 1, 1994·JPEN. Journal of Parenteral and Enteral Nutrition·A StallionJ E Fischer

❮ Previous
Next ❯

Citations

Feb 5, 2002·Peptides·William W Tseng, Carson D Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
R Imoberdorf
© 2022 Meta ULC. All rights reserved